Skip to main content

Table 3 Gestational diabetes and pre-eclamspia in the exercise and control groups, PAMELA study

From: A randomized controlled trial of exercise during pregnancy on maternal and neonatal outcomes: results from the PAMELA study

  Intervention (n = 205) ǂ Control (n = 407)   
  n (%) p OR (95%CI)
Intention-to-treat analysis
Gestational diabetes    0.93  
 Yes 16 (7.8) 31 (7.6)   1.0 (0.6;1.9)
 No 189 (92.2) 376 (92.4)  
Pre-eclampsia    0.98  
 Yes 11 (5.4) 22 (5.4)   1.0 (0.5;2.1)
 No 194 (94.6) 385 (94.6)  
Per protocol analysis (> = 70% exercise sessions) n=85a n = 407   
  n (%)   OR (95%CI)P
Gestational diabetes    0.85  
 Yes 7 (8.2) 31 (7.6)   1.1 (0.5;2.6)
 No 78 (91.8) 376 (92.4)  
Pre-eclampsia    0.79  
 Yes 4 (4.7) 22 (5.4)   0.9 (0.3;2.6)
 No 81 (95.3) 385 (94.6)  
Sensitivity analysis (per protocol 100%)1 n = 23 n = 407   
  n (%)   OR (95%CI)
Gestational diabetes    0.56  
 Yes 1 (4.4) 31 (7.6)   0.6 (0.1-4.2)
 No 22 (95.6) 376 (92.4)  
Pre-eclampsia    0.25  
 Yes 0 22 (5.4)  
 No 23 (100.0) 385 (94.6)  
  1. Data are expressed as number of cases in frequencies absolute and relative (n, %). p > .05; OR: odds ratio; CI: confidence interval. aAt least 48 sessions of the total exercise program
  2. ǂ8 participants in the intervention group did not attend the perinatal follow-up
  3. 19 participants in the control group did not attend the perinatal follow-up
  4. a1 participant adherent to the PAMELA protocol did not attend the perinatal follow-up